Heart Test Laboratories (NASDAQ:HSCS) Releases Earnings Results, Misses Estimates By $0.04 EPS

Heart Test Laboratories (NASDAQ:HSCSGet Free Report) announced its earnings results on Thursday. The company reported ($2.57) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.53) by ($0.04), Zacks reports.

Heart Test Laboratories Stock Performance

NASDAQ:HSCS opened at $2.91 on Friday. The firm’s fifty day moving average price is $3.45 and its 200 day moving average price is $3.43. Heart Test Laboratories has a 1-year low of $2.36 and a 1-year high of $13.50. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.72 and a quick ratio of 1.52. The firm has a market cap of $2.85 million, a price-to-earnings ratio of -0.37 and a beta of 2.76.

Wall Street Analyst Weigh In

Separately, Maxim Group reiterated a “buy” rating and issued a $12.00 price objective on shares of Heart Test Laboratories in a research report on Wednesday, December 18th.

Check Out Our Latest Research Report on Heart Test Laboratories

About Heart Test Laboratories

(Get Free Report)

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.

See Also

Earnings History for Heart Test Laboratories (NASDAQ:HSCS)

Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.